Dr. Sameh Mosaed, MD

Dr. Mosaed practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Mosaed's NPI, 1275613432, was assigned on October 16, 2006. Dr. Mosaed graduated from New York Medical College in 1999. Dr. Mosaed holds California license A83138.

Dr. Mosaed's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Mosaed's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Mosaed is also affiliated with Hoag Hospital Newport Beach. Dmand AI also links Dr. Mosaed to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mosaed practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Mosaed's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Mosaed is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Mosaed is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Mosaed treats.

CMS data shows 4,466 Medicare services from Dr. Mosaed across 15 procedure codes in 2024, for 1,079 Medicare patients. Medicare paid $261,989 for them.

CMS counts 1,079 Medicare patients who saw Dr. Mosaed in 2024. The largest group is 75 to 84, with 487 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mosaed's median patient age at 75, with 55% women.

In 2024, Dr. Mosaed wrote 3,790 Medicare Part D claims for 676 patients. 53% of them were for generic drugs. CMS names the drug for 3,692 of them, across 27 drugs with 11 or more claims each, at $643,716 in total drug cost. In 2023, CMS named 2,970 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mosaed for performance year 2024, reported through an alternative payment model (APM). Dr. Mosaed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 85 procedures of cataract surgery by Dr. Mosaed, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Mosaed, published from 2006 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Trabeculectomy. Dr. Mosaed has published most often in J Glaucoma. Dr. Mosaed's most frequent co-authors are Mason Antone Schmutz, MD, Ken Y. Lin, MD, PhD and Robert N. Weinreb, MD.

Dmand AI links Dr. Mosaed to 1 clinical trial. Conditions studied include Glaucoma, Angle-Closure and Glaucoma.

CMS Open Payments shows 160 general payments to Dr. Mosaed from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Alcon Laboratories Inc paid the most, $38,248.

Dmand AI lists 2 awards for Dr. Mosaed, most recently Regional Top Doctor in 2014.

Dr. Mosaed graduated from New York Medical College in 1999. Dr. Mosaed is a member of AAO.

Dr. Mosaed is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.